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Abstract 10 
Since the onset of microbiology in the late 19th century, scientists have been growing 11 
microorganisms almost exclusively as pure cultures, resulting in a limited and biased 12 
view of the microbial world. Only a paradigm shift in cultivation techniques – from axenic 13 
to mixed cultures – can allow a full comprehension of the (chemical) communication of 14 
microorganisms, with profound consequences for natural product discovery, microbial 15 
ecology, symbiosis, and pathogenesis, to name a few areas. Three main technical 16 
advances during the last decade are fueling the realization of this revolution in 17 
microbiology: microfluidics, next-generation 3D bioprinting, and single-cell 18 
metabolomics. These technological advances can be implemented for large scale, 19 
systematic co-cultivation studies involving three or more microorganisms. In this review, 20 
we present recent trends in microbiology tools and discuss how these can be employed 21 
to decode the chemical language that microorganisms use to communicate.  22 
Keywords 23 
Co-cultivation devices, co-culture, microfluidic devices, natural product discovery, 24 
microbial secondary metabolism, microbial communication 25 
26 
Corrado Nai & Vera Meyer, Tools for co-cultivation of microorganisms, Trends in Microbiology 
2 
 
1. It is time for new discoveries 27 
The biochemist and Sci-Fi author Isaac Asimov (1920-1992) said: “The most common 28 
phrase to hear in science, those who heralds new discoveries, is not ‘Eureka!’ but 29 
‘What? This is funny.’” It is tempting to think that this is what bacteriologist Alexander 30 
Fleming (1881-1955) said following his infamous, fortuitous observation of a Penicillium 31 
chrysogenum mold contamination on a staphylococcal plate [1], leading to the discovery 32 
of the β-lactam penicillin and saving millions of lives ever since. Arguably, the field of 33 
natural product discovery is more subject to serendipitous findings than other research 34 
areas [2], highlighting the need for holistic approaches in the quest of new bioactive 35 
substances (see Glossary). Currently, screening efforts have been drastically 36 
diminished, and the release of antimicrobials in the market has dropped alarmingly [3–37 
5]. Also, candidate molecules and lead compounds often reveal themselves as well-38 
known chemicals [2,6], showing the importance of dereplication efforts. These trends 39 
unfortunately coincide with the rise of bacteria being resistant toward antimicrobials, 40 
including so-called “last-resort drugs” [7]. Chemical approaches such as high-41 
throughput screenings of chemical libraries [8], de novo chemical synthesis [9], or 42 
biotransformation [10] generate new chemical diversity, yet the main and most 43 
promising source of antimicrobials remains microbial secondary metabolism  [5,6,11]. 44 
However, at least 20 years have passed with no new classes of antimicrobials being 45 
identified and the antibiotics pipeline is thus running dry [12]. It is a matter of urgency 46 
that we respond to the rising number of multi-resistant bacteria and fungi [13] in a timely 47 
fashion. Yet sequencing of hundreds of microbial genomes revealed that many species, 48 
in particular filamentous bacteria and fungi, devote a substantial part of their genes (up 49 
to 10-15 %) to secondary metabolism, potentially encoding the “penicillin 2.0” of the new 50 
century [14,15]. Surprisingly, most of these genes are silent, i.e. not expressed under 51 
laboratory cultivation conditions [16]. One obvious explanation for this significant 52 
challenge is that standard microbial cultivations introduced by Robert Koch use axenic 53 
cultures [17], concomitant with environmental conditions that microorganisms never 54 
face in nature: excess of macro- and micronutrients, high water activity, constant 55 
temperature, buffered pH, and isolation from the rest of the microbial world. Therefore, a 56 
substantial part of microorganisms’ secondary metabolites, especially those allowing 57 
them to interactions, communication, alliances, or conflicts with other species, are not 58 
produced. Recent technological advances in co-cultivation devices provide a 59 
tremendous window of opportunity to activate the silent microbial secondary metabolism 60 
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and facilitate the discovery of new bioactive substances by implementing high-61 
throughput co-cultivation screenings (Box 1, Figure 1). 62 
In this review, we present and discuss the impact of new microbiology devices which 63 
enable smart and novel co-cultivation experiments to be performed. We argue that co-64 
cultivation experiments can be implemented, and, if integrated with other emerging tools 65 
such as bioprinting and single-cell analytics, hold great promise to understand microbial 66 
interactions, specifically in the field of natural product discovery. Systematic 67 
investigations of multispecies microbial communities in a combinatorial way have, to the 68 
best of our knowledge, not yet been undertaken with miniaturized devices. Successful 69 
culturing of multispecies communities in this manner will likely have a huge impact on 70 
the discovery of new bioactive substances of microbial origin and will help to shed light 71 
into biosynthetic dark matter. 72 
2. A glimpse in the dark: On microbial secondary metabolism and its role in 73 
nature 74 
Microbial secondary metabolites are small molecules often secreted into the 75 
extracellular space and produced upon stress conditions and/or after entering the post-76 
exponential growth phase. Although the secondary metabolism of microorganisms is not 77 
essential for growth and reproduction in axenic cultures, it is interconnected with the 78 
nutritional status, the general metabolic activity, and the developmental stage [18,19]. 79 
Logically, it must be coupled with primary metabolism, which, in contrast, is essential for 80 
growth and reproduction (Box 2). Primed with simple but ubiquitous cellular building 81 
blocks, such as amino acids or short-chain carboxylic acids, bacterial and fungal 82 
secondary metabolites form a bouquet of unusual and complex chemical structures 83 
harbouring bridged rings, heteropolycyclic or macrolide backbones, as well as cyclic 84 
peptides, which can be decorated with a diverse set of functional groups (Figure 2) [20]. 85 
Chemically, secondary metabolites are mainly classified into non-ribosomal peptides, 86 
polyketides, terpenes, alkaloids, and ribosomally synthesized and post-translationally 87 
modified peptides such as lanthipeptides [20–23]. Functionally, they are bioactive 88 
molecules, some of which have been shown to be pigments, chromophores, 89 
siderophores or melanins [24]. Their activities as antimicrobials, anti-tumorals, 90 
immunosuppressants, cholesterol-lowering agents or toxins makes them attractive for 91 
chemical, pharmaceutical, agricultural and food industries [13]. Given the very specific 92 
function of secondary metabolism, the term “specialized metabolism” might be more 93 
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appropriate, as has been suggested recently [25]. Similarly, the general term “antibiotic” 94 
(from the Greek “anti,” against, and “biosis,” life) to describe antibacterial and 95 
sometimes antifungal drugs is not doing justice to the tremendous range of activities 96 
and targets that these bioactive molecules possess. Recent studies showed that at sub-97 
inhibitory concentrations antibiotics activate expression of a large subset of genes, 98 
including those involved in biofilm formation and virulence [26–28]. Other works have 99 
most recently demonstrated that antibiotics act as inducing agents to enable discovery 100 
of new ones when added exogenously to microbial cultures [29]. This raises the exciting 101 
hypothesis that antibiotics in nature act not only as killing agents but more likely also as 102 
signaling molecules and/or hermetic substances crucial to shape the interaction and 103 
relationship among microbes. Thinking of antibiotics in this way challenges our 104 
anthropocentric view of nature. “Dosis sola facit venenum” (the dose makes the poison) 105 
once said Paracelsus. He might also be right in this context. 106 
3. A shot in the dark: Approaches to activate the silent microbial natural product 107 
reservoir 108 
Actinobacteria and filamentous fungi possess up to 40-80 biosynthetic gene clusters 109 
(BGCs) in each genome, which are predicted to encode the necessary enzymes 110 
required for the synthesis of secondary metabolites; however, only a small fraction of 111 
these compounds have been chemically characterized and linked to specific BGCs. At 112 
present, some hundreds of secondary metabolites of bacterial and fungal origin have 113 
been described [15,21,30–34]. Currently, most approaches to activate the silent 114 
microbial secondary metabolism are performed in axenic cultures and are either 115 
targeted (e.g. activation of a pathway-specific transcriptional factor) or non-targeted 116 
(e.g. activation of epigenetic factors) [35,36]. Whereas the former require a priori 117 
knowledge of a specific BGC [37–39], the latter are less-specific and modify global gene 118 
expression with direct and indirect consequences on the expression of multiple BGCs 119 
[40–47]. Further pleiotropic approaches rely on variations of the growth media (e.g. 120 
OSMAC approach [48]). Only a few try to mimic (inter-kingdom) microbial interactions 121 
in nature by means of co-cultivations on defined media [49–53]. 122 
As opposed to primary metabolism, the correlation between secondary metabolism 123 
genes and their products is not straightforward; not only BGCs are often silent, but it is 124 
cumbersome to associate secondary metabolism profiles with BGCs [30,54]. 125 
Bioinformatic tools (e.g. SMURF, AntiSMASH) for the identification of BGC and/or their 126 
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products [6,55–57] as well as other approaches like the “genomisotopic” ones [58], are 127 
useful in generating a chemotype-to-genotype or genotype-to-chemotype correlation 128 
[6,59]. However, many BGCs, besides the core or key enzymes for the synthesis of 129 
the secondary metabolite “backbone”, possess tailoring enzymes that decorate (e.g. 130 
glycosylate or prenylate) the secondary metabolite with chemical modifications 131 
generating further chemotypes [60], which would be hard to predict by bioinformatics. A 132 
further layer of complexity is added by the fact that two distinct key enzymes might 133 
synthesize the same secondary metabolite (as in the case of the two NRPS-like 134 
proteins encoded by atmelA and apvA in A. terreus, which both produce aspulvinone E 135 
that, depending on the cell type, is converted into melanin or aspulvinones if localised 136 
into the conidia or hyphae, respectively [61]). Moreover, some key enzymes can 137 
participate in the “natural combinatorial biosynthesis” of several secondary 138 
metabolites (as in the synthesis of three pyrrolamide antibiotics by two BGCs in 139 
Streptomyces netropsis DSM40864, i.e. congocidine, distamycin and a 140 
congocidine/distamycin hybrid [62]). An extreme example of this cross chemistry has 141 
been documented for a tripartite, inter-kingdom bacterium-fungus-plant association. 142 
Synthesis of the polyketide-derived phytotoxin rhizoxin by the rice seedling blight fungus 143 
Rhizopus microsporus was shown to be dependent from its own endosymbiontic 144 
bacterium Burkholderia sp. [63]. Recently, rhizoxin was shown to be modified by an 145 
enzyme of the fungal pathogen by adding an oxirane (epoxide) ring and, most 146 
importantly, that this modification is not involved with drug detoxification but with toxicity 147 
enhancements toward the host plant Oryza sativa [64]. The extent of this natural 148 
combinatorial synthesis among different species, which is less studied than approaches 149 
involving heterologous cloning of biosynthetic genes (see e.g. [65]), cannot be 150 
predicted; even with a conservative estimate, many millions bioactive microbial 151 
secondary metabolites potentially exist [11,13,36]. 152 
A parallelism could be drawn with the surpassing of the “one-gene-one-enzyme” 153 
hypothesis in the advancement of our understanding of molecular biology and the 154 
regulation of gene expression. Overcoming the paradigm “one-BGC-one-secondary 155 
metabolite” might prove crucial for the discovery of new secondary metabolites. Co-156 
cultivation studies, in particular when conducted with the appropriate microbiological 157 
tools, will arguably prove crucial to investigate the silent microbial natural product 158 
reservoir. 159 
Corrado Nai & Vera Meyer, Tools for co-cultivation of microorganisms, Trends in Microbiology 
6 
 
4. Understanding life at the microscopic scale 160 
In vitro cultivation of microorganisms as axenic cultures, and the fact that the 161 
overwhelming majority of microorganisms does not grow in the laboratory, results in 162 
both a limited and biased view of the microbial world [25]. Growth of microorganisms at 163 
the microscopic scale, where in particular viscosity, diffusion and surface tension play a 164 
crucial role, is dictated by different physical laws when compared to shaken flasks or 165 
Petri dishes [66]. It was elegantly shown 40 years ago that at the micrometre scale, high 166 
viscosity causes bacteria to move more slowly than diffusing nutrients, resulting in a 167 
passive foraging food strategy [67]. The flux of molecules and nutrients in nature is 168 
certainly not as homogeneous and reproducible as under laboratory growth conditions 169 
[68]. This should result in even higher cellular heterogenicity in populations of 170 
microorganisms, a phenomenon which is recurrently observed and studied in the 171 
laboratory (e.g. [69]). This exerts a further layer of complexity that should be considered 172 
when studying the coordination of microbial gene expression with abiotic and biotic 173 
environmental stimuli. It is important to note how studies that have been successful in 174 
isolating and growing the “microbial dark matter” are often followed by the sequential 175 
passaging (also referred as “subculturing”) of cells as pure cultures, thus resulting in 176 
domestication of them (e.g. [70–72]). All this undermines our knowledge and 177 
understanding on the central role of microbial interactions in nature.  178 
Due to the difficult execution with existing tools, in vitro cultivation of microorganisms as 179 
mixed cultures – be it for antibiotic discovery [53], in the design of synthetic consortia for 180 
metabolic engineering purposes [73–75], or in the study of interactions among 181 
environmental isolates [76] – has been so far mostly limited to bi- or tripartite 182 
association studies [77]. Main challenges for the co-cultivation of microorganisms 183 
involve the uneven growth rate of the strains, as well as the different nutrient 184 
requirements or abiotic incubation conditions. Successful studies involve mixing 185 
different media, application of growth parameters that are suitable for both co-cultivated 186 
partners, and/or the pre-growth of one of the two species to account for different growth 187 
rates. However, it is obvious that to dissect all the possible chemical and physical 188 
interactions when dealing with multi-species communities, essentially limitless 189 
combinatorial possibilities for parameter optimization arise. Consequently, co-cultivation 190 
often represents both a prerequisite, and a bottleneck, to understand microbial ecology, 191 
symbiosis, secondary metabolism, and/or pathogenicity [50,76,78–82].  192 
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5. Current microbiological tools and their potential use in co-cultivation studies 193 
Given the current (r)evolution of microbiological techniques and the recent exponential-194 
like increase in microbial co-cultivation studies (Figure 1), tools for co-cultivation of 195 
microorganisms are still in their infancy. Novel, promising microbiological advances, and 196 
their possible uses in co-cultivation studies, are summarized in Table 1 and discussed 197 
below.  198 
Classical cultivations and miniaturized versions thereof 199 
Classical techniques remain the “gold standard” for microbiology experiments to grow, 200 
maintain, or domesticate strains. They are easy to perform and allow the isolation of 201 
sufficient amounts of secondary metabolites for subsequent chemical analysis, but also 202 
require considerable amount of consumables (media, materials) and time. Co-203 
cultivations studies are often performed based on serendipitous associations of 204 
strains/species [81], educated guesses [51], or are painstakingly executed by bi-partite 205 
screenings [50]. A bias toward cultivable, well-studied species known to produce many 206 
secondary metabolites (e.g. Streptomyces spp. or Aspergillus spp.) is observed.  207 
Classical methods are successfully used for the screening of new isolates with 208 
antimicrobial activity. Kawaguchi et al. [83] combined the plating of soil-derived fungi 209 
with a bioactivity screening against Candida albicans. A separation of the 210 
strains/species after co-cultivation is often difficult, but can be achieved with further 211 
tools (e.g. semi-permeable membranes [72,84] or dialysis culture flasks for the physical 212 
separation of cells while maintaining chemical contact [85]).Miniaturization of classical 213 
techniques facilitates the execution of co-cultivation experiments. The Biolog System 214 
[86], for example, which is used to characterize the phenotype of strains growing in 215 
different chemical environment in 96-well plate format, can be used to assess the 216 
influence of varying abiotic conditions on co-cultivated species or characterize the 217 
physiology of different complex microbial communities (e.g. [87]). With the development 218 
of micro-Petri dishes, Ingham et al. [88] created a porous ceramic chip (36x8 cm) that 219 
can be placed on top of a regular agar plate and be used for high-throughput 220 
screenings. Embedding or streaking a co-cultivation partner in/on the bottom agar would 221 
allow the high throughput, pairwise screening of the chemical interaction with the cells in 222 
the micro-compartments. The integration of classical plating techniques with nanospray 223 
desorption electrospray ionization (NanoDESI) and matrix-assisted laser desorption 224 
ionization–time of flight (MALDI-TOF), is used in the so-called imaging mass 225 
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spectrometry (IMS) to investigate chemical signatures of interspecies microbial 226 
interactions [89,90]. 227 
Microfluidic devices 228 
Microfluidic devices [66,91] are tools that allow the handling of liquids in µm to pm scale 229 
to create liquid-liquid interfaces (with miscible and immiscible fluids), e.g. using laminar 230 
flows. The devices are often designed with computer-aided design (CAD) software and 231 
produced by engraving, micromachining or moulding of materials as silicones, ceramics 232 
or acrylic glasses. They are often connected with microscopy and permit single-cell 233 
analytics as well as parallel, miniaturized experiments, holding great potential for co-234 
cultivation studies. Physical conditions in microfluidic devices are more controllable and 235 
representative for life at the microscopic scale, while miniaturization allows parallel 236 
experiments and high surface area-to-volume ratio, which facilitates diffusion of 237 
secreted metabolites in microsystems. Automation might be foreseen, and the devices 238 
are also sometimes referred as “Lab-on-a-chip” or microelectromechanical systems 239 
(MEMS) [92]. The small working volumes and the capability of microfluidic devices to 240 
precisely control growth dynamics, e.g. through the flow of media and device-specific 241 
physical micro-constrictions, make them suitable for single-cell analysis as well as 242 
investigation of microbial community assembly [93–96]. 243 
Hesselman et al. [97] developed a reusable, two-compartment device for co-cultivation 244 
experiments between Escherichia coli, and the nematode Caenorhabditis elegans, 245 
which were separated by microsieves. An open microfluidic platform (a.k.a. suspended 246 
microfluidic) based on liquid surface tension, and capillary flow, was shown by Casavant 247 
et al. [98] to be suitable to investigate chemotaxis in eukaryotic cells. The air-liquid 248 
interface facilitates the extraction of metabolites, while multiplexing of capillaries (“µDot 249 
device”) generates several distinct compartments within the platform. By using 250 
hydrogels between the capillaries, chemical and physical contacts can be maintained 251 
and prevented, respectively. By designing a high-throughput microfluidic platform with 252 
hundreds of physically separated, flow-through chambers, connected with time-lapse 253 
microscopy, Grünberger et al. [93] generated single-cell data with spatiotemporal 254 
resolution, including morphology and cell division dynamics, for Corynebacterium 255 
glutamicum. Importantly, the authors later showed the suitability of a similar device to 256 
investigate population heterogeneity in the filamentous fungus P. chrysogenum [94]. 257 
Due to flow-through of media in the microfabricated device, one condition at the time 258 
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can be investigated, which is generally comparable to classical co-cultivation studies. 259 
Uniquely however, miniaturization allows feeding with pulses of different media, or 260 
facilitates the analysis of downstream, inter-species effects of secreted chemicals (e.g. 261 
with the sequential combinatorial arrangements of species along the flow-through 262 
direction). In microfluidic devices, especially those with several hundred compartments, 263 
cells are “brought” into place by dip-loading and capillary action, microinjection, or 264 
seeding of cells into micro-compartments, hence often relying on the stochastic 265 
inoculation of cells. The major challenge for co-cultivation screenings using microfluidic 266 
devices would be to precisely inoculate different combinations of complex microbial 267 
consortia into miniaturized devices with hundreds of distinct compartments.  268 
Encapsulation techniques  269 
A special version of microfluidics is encapsulation technology, where droplets are 270 
dispersed in different phases (e.g. water-oil-water). Droplet-based approaches rely on 271 
small volumes of fluids and therefore could be considered as a subset of microfluidic 272 
approaches. Micro-compartments are generated by confining cells in emulsions of 273 
agarose-based, aqueous or gel (e.g. polymeric compounds like PDMS) microdroplets. 274 
Microdroplets allow diffusion of molecules and are sessile, semi-permeable containers 275 
(with both size and hydrophobicity of chemicals influencing diffusion). Multiple species, 276 
as well as single cells, can be encapsulated in microdroplets, thus allowing investigation 277 
of promiscuous physicochemical (cell-cell) contacts or of indirect chemical interactions 278 
without physical ones. Being physicochemically confined, cells cannot escape the 279 
encapsulation, while the size of droplets can be controlled by osmotic diffusion of water 280 
[99].  281 
First described in the 1950s in a seminal paper to observe growth and motility of single 282 
cells [100], the technology was further developed to grow uncultured microorganisms 283 
under low-nutrient media in percolating columns [101], or to perform high-throughput 284 
chemical sensitivity screenings [102]. The encapsulation approach has proven useful to 285 
investigate synergistic effects of microorganisms in bi- and tri-partite assays [103], 286 
where the authors showed that spatial organization of microorganisms is involved in the 287 
establishment of syntrophy. Recently, Niepa et al. [99] probed bacterial-fungal 288 
interactions and demonstrated antagonistic dynamics between P. aeruginosa and C. 289 
albicans, showing differences upon physicochemical (eradication C. albicans upon co-290 
localization of P. aeruginosa) and chemical interactions of the species (repression of 291 
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filamentous growth of the fungus when the bacterium is excluded from the 292 
microdroplets). 293 
The SplitChip [104], in which cells grow in compartments that are subsequently split into 294 
two, relies on microfluidics and could be considered as a miniaturized version of replica 295 
plating. Originally developed for differential analysis of the split compartments, i.e. for 296 
both scale-up (e.g. to grow new uncultured species) and destructive analysis (e.g. 297 
molecular methods like colony PCR), the technology could be useful in co-cultivation 298 
experiments. For example, upon splitting, metabolomics analysis of one split 299 
compartment, or transplantation of microbial communities, can be easily done. 300 
Using the microfluidic streak plate [105], high-throughput cultivation of cells in nL-301 
volumes in regular petri dishes filled with an inert carrier oil by manual or robotic 302 
streaking can be achieved. This technology was used to identify a complex microbial 303 
community within a droplet able to degrade polycyclic aromatic hydrocarbons. As for 304 
microfluidic approaches, the encapsulation of cells – especially when dealing with 305 
complex environmental samples – might be dictated by chance. Even if this issue is 306 
overcome by the large amount of droplets that can be generated and screened, a way 307 
to modulate droplets dynamics would represent a great advantage for co-cultivation 308 
screenings. While volume, composition and stability of microdroplets can be 309 
manipulated [106], their precise orientation/localization in space cannot yet be 310 
controlled. 311 
3D-bioprinting 312 
Modulating the position of microdroplets might be superfluous when microbial 313 
communities become established via 3D-bioprinting, where complex structures can be 314 
designed in any desired geometry using a gelatinous matrix [107]. Investigating 315 
nonsperoidal geometries of bi-partite microbial communities, a recent study 316 
demonstrated that nesting Staphylococcus aureus within structured shells of P. 317 
aeruginosa increases resistance of the first toward β-lactams [107]. The porous nature 318 
of the matrix and the versatility in producing any desired geometry makes the technique 319 
attractive to study structured microbial communities. 320 
6. Concluding Remarks 321 
 “Prediction is very difficult, especially about the future” said the physicist Niels Bohr 322 
(1885-1962). If one is to extrapolate from the present trend of increasing studies on 323 
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microbial co-culture and the currently available toolset (Table 1), and to judge the 324 
potential hidden in the “microbial/biosynthetic dark matter,” then the field of microbial co-325 
cultivation holds great promises for the future and will continue to thrive. The road to 326 
natural product discovery is long and arduous, and microbial cultivation is just one 327 
bottleneck in drug discovery, which includes elucidation of bioactivity mechanism and 328 
chemical structure as well as clinical trials. We argue that since microbial (co-329 
)cultivations are often the initial step in drug discovery, implementation of co-cultivation 330 
tools will benefit the whole pipeline.  331 
Borrowing a concept from computer science, the Moore’s Law of Microbiology has 332 
been formulated [108], drawing a parallelism between the miniaturization of microbial 333 
cultures and the number of transistors per chip in microelectronics. Microfabrication 334 
holds great promise for microbiology [109], and the single cell size limit will be reached 335 
earlier than the single atom limit in microelectronics [108]. However, device 336 
compartments need to accommodate complex, multi-microbial communities resembling 337 
natural ones, and miniaturization per se is not the only pivotal factor for the execution of 338 
co-cultivation experiments (Figure 3). Integration with downstream analysis is crucial, as 339 
well as the ability to discriminate between chemical and physicochemical effect among 340 
promiscuous cultures. For example, the open microscale platform by Barkal et al. [110] 341 
is a microtiter plate-size device investigating the effect of culture microenvironments 342 
during microbial (co-)cultivations, with an integrated metabolite extraction platform 343 
facilitating downstream analytics. Importantly, the authors showed that different 344 
geometries of the compartments influence the profile of secondary metabolites 345 
produced by A. nidulans, and implemented the device to allow co-cultivation of e.g. the 346 
plant pathogen Ralstonia solonacerum and A. flavus [110]. 347 
Engineering of microbial consortia is, although technical challenging, implementable for 348 
industrial and biotech purposes [111,112]. The group of Akio Ozaki showed large-scale 349 
production of commercially-valuable mono- and oligosaccharides by tri-partite cultures 350 
of recombinant E. coli strains and Corynebacterium ammoniagenes [113,114]. Ying-Jin 351 
Yuan and colleagues used co-cultures of Ketogulonigenium vulgare and Bacillus 352 
megaterium for the industrial production of vitamin C [115], thus validating the use of 353 
stable, large-scale multispecies consortia of microorganisms for applied purposes.  354 
An aspect that should be considered is that natural products are often uncovered by 355 
studying the associations of microorganisms with plants [116] or insects [117,118]. 356 
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Some of the tools discussed in this review have been shown to be useful to grow 357 
nematodes [97], in dissecting the effect of fungal secondary metabolites on zebrafish 358 
(vertebrate) embryos [119], or study chemoattraction and 3D-growth of cancer cells 359 
[98], which opens new exciting prospects for the study of microbial interactions with 360 
multicellular eukaryotes. It is argued how a theoretical framework [120] and the 361 
integration of experimental data with mathematical modelling [121] would largely benefit 362 
the fields of microbial ecology and mixed-culture studies. We believe that co-cultivation 363 
experiments mostly neglect synergistic interactions among microorganisms as well as 364 
the role of volatile compounds as signaling molecules (see Outstanding Questions) 365 
[122,123]. 366 
Crucially, co-cultivation experiments can be done, as opposed to molecular approaches, 367 
without extensive knowledge of the strains used [2,6]. Serendipity in natural product 368 
discovery, and by extension in science, is not to equate to sheer luck. Creating the 369 
nourishing environment for breakthrough discovery by having the appropriate tools, 370 
theoretical framework or design of experiment is very much a prerequisite. We are 371 
convinced that implementation of current microbiology tools and their application in co-372 
cultivation screenings will be a turning point for natural product discovery. In line with 373 
Isaac Asimov, we dare to predict that scientists on their way to new discoveries in the 374 
secondary metabolism of microbes will increasingly say “What?” again. 375 
376 




A limited, biased, and anthropocentric view of the microbial world with focus on fast-378 
growing copiotrophic species has emerged from classical axenic cultivation 379 
approaches. 380 
Recent (meta)genomic insights unveiled the potential hidden in microbial diversity. 381 
However, cultivation-independent approaches cannot replace cultivation techniques. 382 
Cultivation techniques have to evolve further – from axenic to mixed cultures – to fully 383 
understand the microbial world. 384 
Newly emerged tools including microfluidics, bioprinting, high-throughput screening, and 385 
single-cell analytics need to be fully implemented and integrated with existing 386 
(microbiology) techniques to systematically investigate and exploit microbial co-cultures.387 
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Outstanding Questions 388 
Which opportunities and challenges offer miniaturization of microbiology tools for co-389 
cultivation studies? How can reproducibility of results, as well as stability of complex 390 
microbial communities, be guaranteed as is the case for classical, macroscopic 391 
experiments? Can miniaturization address these issues by the execution of multiple, 392 
parallel experiments?  Is reaching the single cell limit in microcompartments hindering 393 
the investigation of complex, multispecies consortia? 394 
Which tools to systematically investigate multi-partite microbial associations in co-395 
cultivation screenings (i.e. with more than two or three strains/species) will be 396 
established? How can uncultured species be grown/exploited without domestication 397 
steps, thus unleashing the potential hidden in the biosynthetic dark matter? Would new 398 
tools allow the investigation of non-antibiotic effects of secondary metabolites at sub-399 
inhibitory concentrations? 400 
How will techniques like metabolomics and other “-omics” techniques, microscopy, IMS 401 
be increasingly integrated with the proper theoretical framework for the systematic 402 
investigation of complex microbial interactions? How can miniaturized experiments be 403 
up-scaled to validate the results and if necessary to produce sufficient amounts of 404 
induced secondary metabolites? 405 
How can an effective design of experiment (DoE) to activate the silent secondary 406 
metabolism of microorganisms by co-cultivation experiments be ideated, taking into 407 
consideration the effects of physicochemical (cell-cell) and chemical signals (diffusible 408 
secondary metabolites, including volatile compounds) as well as microscale geometries 409 
and spatial structures of microbial communities?  410 
411 




Axenic culture: pure culture of microorganisms, i.e. of only one species/strain. 413 
Bioactive substances: chemical molecules showing bioactivity e.g. as antimicrobials, 414 
anti-tumour agents, immunosuppressants or anti-cholesterol agents. Antimicrobials 415 
(often referred to as antibiotics, antifungals and/or antibacterials) specifically kill or 416 
inhibit growth of fungi or bacteria.  417 
Biosynthetic dark matter: are the unknown products of silent BGC of known species 418 
and, by extension, putative new bioactive substances from the uncultured microbial 419 
diversity. 420 
Biosynthetic gene cluster (BGC): at least two physically-clustered genes encoding 421 
enzymes acting in concert in a biosynthesis pathway. Inactive BGCs are often referred 422 
as “silent,” “cryptic” or “orphan” genes. 423 
Co-cultivation screenings: here we arbitrarily refer to this term to indicate the 424 
systematic, miniaturized and/or parallel investigation of co-culture of microorganisms 425 
where two, three or more species/strains can coexist, as opposed to “classical” studies 426 
often based on educated guesses and mainly investigating one bi-partite interaction at 427 
the time (e.g. in Erlenmeyer flasks or Petri dish). 428 
Copiotroph: (micro-)organism that thrive in niches rich in available nutrients as 429 
opposed to oligotroph. Copiotrophic environments with nutrient-rich solutions are the 430 
standard cultivation media in microbiology whereas they are not prevalent in nature.  431 
Core/key enzyme: the enzyme for the synthesis the secondary metabolite “backbone” 432 
which can be further modified by tailoring enzymes; usually, there is one key enzyme 433 
pro BGC, in particular the multi-domain enzymes non-ribosomal peptide synthetase 434 
(NRPS), polyketide synthase (PKS) or NRPS-PKS hybrid. 435 
Dereplication: efforts to discover truly novel substances as opposed to the 436 
detection/isolation of known bioactive molecules, which is a recurrent phenomenon in 437 
natural product discovery. 438 
Domestication: the step(s) employed to grow uncultured species. This often involves 439 
the sequential passaging of pure microcolonies on common laboratory media to obtain 440 
macroscopic colonies e.g. on a Petri dish. 441 
Hormetic substance: chemical showing a dose-dependent effect on a target 442 
cell/organism as recently shown for antibiotics (i.e. enhancement of biofilm formation at 443 
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sub-inhibitory concentration while lethal effects at high dosage); the phenomenon is 444 
called hormesis. 445 
Microbial dark matter: the fraction of microorganisms that cannot (yet) be cultivated in 446 
the laboratory.  447 
Moore’s Law of Microbiology: a parallelism between microelectronics and 448 
microbiology, comparing the predicted doubling, every two years, in the number of 449 
transistors per chip (microelectronics) with that of compartments per cultivation tool 450 
(microbiology). Also in microbiology, this trend is fueled by 451 
miniaturization/microfabrication. 452 
Natural combinatorial synthesis: the synthesis of secondary metabolites by the cross 453 
chemistry of different BGCs within an organism or, possibly, among different species. 454 
OSMAC: one-strain-many-compounds, an approach to increase the portfolio of 455 
secondary metabolites produced by one strain by varying the cultivation conditions. 456 
Secondary metabolism: the branch of the cellular biochemical reactions that, as 457 
opposed to the primary metabolism, is not essential for growth, development, 458 
reproduction and basic cellular homeostasis. The products are called secondary 459 
metabolites (occasionally also referred to as idiolites, exometabolites or extrolites). 460 
Genes for the production of secondary metabolites are often organized in BGCs. 461 
Siderophore: iron-chelating molecule increasing the solubility and thus bioavailability of 462 
extracellular, oxidized ferric iron. 463 
Syntrophy: cross-feeding of two or more species/strains which show 464 
nutritional/metabolic interdependence. 465 
Uncultured microorganism: also non-cultured, uncultivable, unculturable; 466 
microorganisms that fall into the “microbial dark matter.” This is not synonymous with 467 
viable but nonculturable cells (VBNC), which are cells that due to metabolic imbalances 468 
or other unknown reasons enter into a physiologically inactive (dormant) state and are 469 
recalcitrant to growth on otherwise favorable media. Since both phenomena are not yet 470 
fully understood, a distinction is not always possible. 471 
472 




Figure 1. Exponential-like increase of publications on microbial co-cultivations in 474 
the last ~ 45 years. Plotted are the search results on PubMed with the query 475 
("microorganisms"[TIAB] OR "microbial"[TIAB] OR "fungi"[TIAB] OR "fungal"[TIAB] OR 476 
"bacteria"[TIAB] OR "bacterial"[TIAB]) AND ("co-culture"[TIAB] OR "coculture"[TIAB] OR 477 
"mixed fermentation"[TIAB] OR "mixed culture"[TIAB] OR "combined culture"[TIAB] OR 478 
“co-cultivation”[TIAB]); only titles and abstracts were queried in the literature survey, 479 
resulting in 3’700 hits (as of March 2017). For 2017, an estimated number is given 480 
which we extrapolated from the ca. 140 papers published in the first 3 months. Please 481 
note that some studies, including articles discussed in the text, use a different 482 
terminology, in particular in the field of environmental microbiology, microbiome 483 
research, metabolic engineering or synthetic biology (e.g. “in vitro community 484 
reconstruction,” “species-specific/multispecies/interspecies/biotic interactions,” “one-to-485 
one competition,” “microbial consortia engineering,” “polycultures,” etc.). Therefore, the 486 
number of publications is likely higher, especially for the last decade. Before 1970, only 487 
single-digit hits/year were obtained (20 in total; not shown). 488 
489 




Figure 2. Selected examples of microbial secondary metabolites demonstrating 491 
the diversity of chemical structures. Shown are the natural products of fungal and 492 
bacterial origin 1 lagriene (polyketide), 2 sinapigladioside (aromatic glycoside with 493 
isothiocyanate group), 3-4 rhodostreptomycins A and B (aminoglycosides, isomers), 5 494 
biphenomycin A (cyclic peptide), 6-7 emericellamides A and B (cyclodepsipeptides), 8-9 495 
emestrins A and B (macrocyclic piperazine derivates), 10 bacilysin (non-ribosomal 496 
peptide with epoxide group) and 11 BU-4704 (xanthocillin analogue with cyanide 497 
groups). The secondary metabolites are induced by co-cultivation (for details see 498 
references [36,82]). 499 
500 




gure 3. Selected microbiology tools and their suitability for co-cultivation studies.  502 
Shown are classical microbiology tools (green), microfluidic devices (red), encapsulation 503 
approaches (purple) and other tools (yellow). In addition to miniaturization, integrated 504 
techniques such as microscopy or metabolomics extraction increase potential for co-505 
cultivation screenings. For details see text (please note that the devices are not in scale; 506 
level of miniaturization refers to the number of compartments and not to the size of the 507 
device or compartments). Abbreviations: PD: Petri dish; ERL: Erlenmeyer flask; MTP: 508 
microtiter plate; mPD: micro-Petri dish [88]; SMF: suspended microfluidics [98]; HTMF: 509 
high-throughput microfluidic [93]; OCCS: on chip culture system [124]; LC: Living Chip 510 
[92]; SC: Split Chip [104]; MSP: microfluidic streak plate [105];  GM: gel microdroplets 511 
[101,103]; iChip: isolation chip [84]; OMP: open microscale platform [110]; LVMC: low-512 
volume migration chamber [119]; 3DP: 3D printing [107]. 513 
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Key Table – Table 1. Overview of current microbiological tools and their amenability for co-cultivation studies. 
Device or technique 
Use in co-cultivation studies 
Relevant refs. 
Pros Cons Potential for implementation 
Classical cultivations and miniaturized versions thereof  
Surface cultivation (Petri dishes) 
First introduced by Robert Koch and 
Julius Petri and still an irreplaceable 
step for microbiological analyses  
 
Easy to perform; different plating 
geometries and 
compartmentalization possible; 
can be coupled with analytic 
techniques like IMS 
A “common ground” (medium) 
for growth of both organisms 
required; experiments mostly 
based on educated guesses. 
Very limited. Screenings often 
done to grow new species with a 




(Erlenmeyer flasks)  
Cells in liquid cultures under vigorous 
shaking to allow high mass transfer 
of nutrients and oxygen  
Easy to perform; analysis of 
culture supernatant allows 
investigation of secreted 
chemicals; controls (e.g. with 
heat-deactivated cells) usually 
necessary 
Same as above. Separation of 
cells/species after contacts 
difficult; different growth rates 
usually not taken into 
consideration. 
Very limited. Dialysis culture 
flasks (described ca. 1900) with a 
semi-permeable membrane 
prevent cell-cell contacts 
[85] 
Microtiter plates 
12- to 1536-well plates for 
miniaturized growth of cells (mostly 
static or with mild shaking in liquid, 
solid or viscous media) 
Same as above Same as above Limited. Compartmentalization 
can be achieved with inserts 
(transwells); varying abiotic 
conditions can be assessed with 
the Biolog System 
[86] 
Micro-Petri dish  
A porous ceramic sheet (1 mio. 
compartments 7 x 7 µm) placed on 
top of agar; used for high-throughput 
screenings (enzyme-based, 
fluorescent) or high-density culturing 
Presence of air-liquid interface 
favors oxygen transfer; placing 
on top of agar allow a reservoir 
for media, waste product and 
liquid (less evaporation) as well 
as transfers to different media 
Stochastic inoculation by 
overflowing with cell suspension; 
Not very suitable for 
investigating tri-partite 
interactions 
High, given that one can precisely 
inoculate cells into the micro-
compartments; suitable for high-
throughput, pair-wise screening 
with a co-cultivation partner in the 
bottom agar  
[88] 
Microfluidic devices  
Microfluidic cultivation platforms  
Microfluidic devices with flow-through 
of medium for single cell analysis of 
growth/morphology, usually based on 
trapping of single cells  
Flow-through of liquid suitable 
for collecting and analyzing 
secreted metabolites 
Microscopy is less informative 
on cell-cell interactions; 
controlled inoculation of multiple 
species/strains might prove 
challenging 
Possible through serial 
combinations of single cell 
compartments (connection of 
flow-through) or (stochastic) 
trapping of multiple species  
[93–96] 
Multi-platform flow device 
Porous aluminum oxide microsieve 
(ca. 0,2 µm) connecting two flow-
through channels 
No need for membranes; 
chemical contact is guaranteed; 
fluorescence microscopy 
possible 
Current design relies on 
educated guesses and by-partite 
co-cultivations; used to grow 
nematodes as well 
Limited with the existing design; 
new designs are possible 
[97] 
On-chip culture system Might allow fine-tuned analysis Sealed chambers do not allow Limited. Currently based on [124] 
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Miniaturized chambers sealed with 
semi-permeable membrane for the 
isolated growth and microscopical 
analysis of single cells 
of different ratio of co-cultivated 
species; media exchange 
through overflow/flow-through 
possible 
exchange of metabolites among 
compartments of plasticity in 
experimental design (e.g. no 
reiterated opening and closing 
the system possible) 
educated guesses of interacting 
partners or random inoculation of 
environmental samples; 
microscopy less informative on 
the specific interactions 
Microscale capillary flow 
A suspended microfluidic tool as 
open platform with an air-liquid 
interface 
Multiplexing possible (“µDot” 
device); compartments can be 
physically separated by 
hydrogels (chemical contact 
maintained); multilayer biphasic 
system allows metabolomic 
analysis 
Flow of fluids limited to the size 
of the chambers (i.e. no flow-
through as in refs. [94,124])  
High due to multiplexing of 




Living Chip or GigaMatrix with 
10,000-100,000 through-holes 
retaining fluid (ca. 50-200 nL) by 
capillary action; inoculation by dip-
loading or microinjection 
Through-holes can be 
inoculated differently by precise 
micro-injection; readily 
interfaced with microtiter plates 
(injection or downstream 
handling) 
Read out by microscopy less 
informative for metabolic 
changes; stacking does not 
prevent cell-cell contacts 
Might be high due to stacking of 
chips, yet still speculative; growth 
of filamentous species might be 
problematic 
[92,127] 
Encapsulation technique (droplet-based approaches)  
Microfluidic streak plate 
Grow of single cells in nL droplets; 
streaking by hand or robotically with 
a special spindle motor 
Has yet to be addressed; might 
be possible by integrating 
existing technologies 
Inert carrier oil suitable for 
containment of cells in water 
microdroplets but not to embed 
a co-cultivation partner 
Limited. Mostly done to 
grow/screen uncultured species 
[105] 
SplitChip 
1000 microcompartments with two 
juxtaposed wells for single cell 
inoculation and splitting for separate 
analysis of replica cultures 
Miniaturized version of replica 
plating allowing differential 
analysis/downstream handling of 
split compartments 
Splitting might facilitate 
downstream analysis, but not 
the design of multi-partite co-
cultivation experiments  
High, suitable for single-cell 
metabolomics 
[104] 
Gel microdroplets or 
“nanocultures” 
Encapsulation of single cells into 
agarose-based droplets, water-oil-
water emulsions or 
polydimethylsiloxane (PDMS), e.g. 
for cultivation in percolating columns 
Both physicochemical and 
chemical contacts possible; high 
surface area-to-volume ratio 
facilitates diffusion; water-
permeable microniches allow 
control of volume compartment, 
e.g. by osmosis 
Fragility of emulsion droplets 
and limited understanding of 
mass transfer hinder long term 
studies; chemical nature of 
substances (polarity, size) might 
be an issue; only spheroid 
geometries 
Very high. Isolation of droplet and 
metabolome analysis should be 
possible 
[99,101,103] 
Other devices/techniques  
Soil chambers, e.g. iChip Natural environment is used as In situ cultivation might dictate Limited. Not envisioned by the [71,84] 
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Microorganisms are re-implanted into 
their original environment and grown 
in situ 
stimulus to grow the “microbial 
dark matter” (diffusion of 
chemicals) 
conditions and limit the 
controlled introduction of further 
species/strain; size of 
compartments too small for 
multispecies consortia 
method, but instead used to grow 
new species 
Hollow-fibre membrane chamber 
Counterpart of the iChip, but more 
technical challenging; flux of fluid can 
be controlled better 
Since fluids can be better 
controlled, supernatants of 
different cells can be screened 
in parallel 
No cell-cell contacts present Similar as above [128] 
Low-volume migration chamber 
Allow in vivo neutrophil migration 
study in zebrafish; imaging possible 
(microscopy); ports for loading and 
removal of media and wastes 
Designed to dissect function of 
secondary metabolites 
(“function-omic” platform); 
arrayed chambers with 
automation possible 
Performed with purified 
chemicals; mixing of both media 
through migration channels 
(dissipation of gradients unless 
media is constantly removed/re-
filling) 
Likely high, but still need to be 
demonstrated for living cells; 
especially useful to investigate 
chemoattraction 
[119] 
Open microscale platform 
Open platform for co-cultivation and 
metabolomic analysis 
Integrated liquid-liquid extraction 
protocol; open nature of the 
device (liquid-air interface) 
particularly suitable for 
downstream analyses;  
geometry of microchambers is 
taken into consideration 
Co-culture design intended for 
bi-partite co-cultures; flow of 
media is limited or done by 
pipetting (static cultivation 
conditions); no automation 
High. The device was developed 
with the purpose of performing 
metabolomics analysis and co-
cultivation experiments; multi-




Printing of different geometries 
(adjacent, nested, free-floating 
colonies) with laser-based 
lithographic technique with gelatin 
Diffusion of chemical possible; 
gelatin is porous and 
biocompatible; high-versatility in 
defining an exact 3D structure of 
microbial communities 
Rational design of 3D structure 
required; immobilization of cells 
might represent a less dynamic 
situation than that of biofilms in 
nature; costs relatively high 
High. Especially interesting to 
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Box 1. On past and present trends in the (co-)cultivation of microorganisms 514 
Microbiological tools have evolved arguably not as much as tools in other technical 515 
fields. After the first cultivation of pure colonies of bacteria by Robert Koch (1843-516 
1910) around 1880 [17,129], axenic growth of strains either on solid or in liquid media 517 
belongs to the standard and irreplaceable routine in microbiology. This is dictated by 518 
practical reasons, yet microorganisms are alienated from their natural environment, 519 
which is characterized by complex, inhomogeneous substrata and promiscuous 520 
associations of microorganisms (per some estimates, one gram of soil harbors 521 
between 10,000-50,000 different species [130]).  522 
Plating experiments yield only a fraction of the cells observed under the microscope, 523 
a phenomenon known since many decades as the “Great Plate Count Anomaly” 524 
[131]. Molecular techniques, in particular metagenomics and fluorescent in situ 525 
hybridisation (FISH), uncovered how these cells are not remnants of dead 526 
microorganisms but alive and well – and extremely diverse, representing an estimate 527 
99,9% of all microorganisms [132]. Borrowing a terminology from astrophysics, this 528 
wealth of “uncultivable” diversity is referred as the “microbial dark matter” [133,134]. 529 
Efforts focusing on growing the seemingly inaccessible microbial wealth from sites as 530 
diverse as the human microbiome [135] or soil habitats [71,84] often foresee the 531 
integration of different approaches or new microbiology tools. 532 
Given the importance of microbial communication in the production of secondary 533 
metabolites, microorganisms represent a treasure chest for natural product 534 
discovery. This is illustrated by the tremendous momentum that co-cultivation studies 535 
are currently gaining (Figure 1), with the first reported study on “mixed cultures” 536 
dating back to 1918 [136]. The author analyzed co-cultures of E. coli and Bacillus 537 
paratyphosus and concluded that “it is hoped that by these investigations material of 538 
particular interest relating to the biochemical and physiological processes within the 539 
bacterial culture will be obtained.” [136] One century later, researchers in the fields of 540 
microbiology, biotechnology and natural product discovery still explore co-cultivation 541 
experiments as one way to pursue these questions. Given the multiple names given 542 
to these studies by the community of microbiologists, we propose to use a unique 543 
nomenclature to unify different fields of microbiology by always including the terms 544 
“co-cultivation”, “co-cultures” (hyphenated) or “mixed cultures” in the abstract or 545 
keywords. 546 
Corrado Nai & Vera Meyer, Tools for co-cultivation of microorganisms, Trends in Microbiology 
24 
 
A survey revealed that more than 20,000 natural products with antimicrobial activity 547 
from microorganisms have been discovered [137], with around two-thirds of all 548 
therapeutically-used antimicrobials like tetracyclines, aminoglycosides, 549 
chloramphenicol, macrolides, and glycopeptides coming from actinobacteria and 550 
members of the genus Streptomyces as undisputed monopolizers [5,6,11]. When 551 
filamentous fungi (producing substances like penicillins and cephalosporins) and 552 
non-filamentous bacteria (e.g. myxobacteria, Pseudomonas spp.) are included, this 553 
value reaches 80-90%; among the remaining substances, many are semi-synthetical 554 
(i.e. derivatives of natural products) [3]. Despite the extremely specific action of 555 
antibiotics and the huge advances in pharmacology since the introduction of the 556 
“magic bullet” concept by Paul Ehrlich (1854-1915) to describe chemotherapeutic 557 
agents, antibiotics are still used rather unspecifically and at high dosage. 558 
Box 2. On the ways to activate the microbial secondary metabolism and its link 559 
with the primary metabolism  560 
In Streptomycetes, both the carbon and the amino sugar metabolism influence 561 
antibiotic production [138]. Rigali et al. [139] showed that monomeric N-562 
acetylglucosamine (GlcNAc) added exogenously on minimal media curbed 563 
production of the polyketide (PK) actinorhodin in several Streptomyces spp. 564 
Importantly, the authors provided convincing evidences for a link between nutritional 565 
status, developmental stage and activation of the secondary metabolism. Giving the 566 
ubiquitous presence of the amino sugar GlcNAc and its homopolymeric form chitin in 567 
nature in the cell wall of fungi, the exoskeleton of insects and the extracellular matrix 568 
of mammals (hyaluronic acid) or in its heteropolymeric from in the cell wall of bacteria 569 
(murein), this finding raises interesting implications for the influence of exogenous 570 
sugar monomers on antibiotic production upon multi-species interactions. During a 571 
chemical screening with over 30,000 small molecules to identify conditions inducing 572 
antibiotic production in actinomycetes, Craney et al. [140] observed more 573 
pigmentation (among other due to the increased production of the antibiotics 574 
actinorhodin and germicidins) by S. coelicolor upon addition of “ARCs” (antibiotic-575 
remodelling compounds). These small chemicals showed structural similarities and 576 
comparable activities with inhibitors of fatty acid (FA) biosynthesis. Both FA and PK 577 
synthesis requires the ubiquitous precursors acetyl-CoA and malonyl-CoA, thus 578 
linking primary and secondary metabolism. Partial inhibition of FA synthesis resulted 579 
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in a physiological imbalance and an increased availability of substrates for the 580 
synthesis of secondary metabolites. These and other studies highlight how the term 581 
“secondary metabolism” might be misleading, and in light of the multiple functions 582 
that it exerts in nature, it has been proposed to refer to it as a “specialized 583 
metabolism” [141].  584 
Crucially, these insights reveal ways to activate the microbial secondary metabolism 585 
(Table I) and unlock the potential hidden in the biosynthetic dark matter. 586 
[16,35,142,143]. These are divided into knowledge-based and general approaches. 587 
For the former, the availability of suitable production hosts and/or genetic engineering 588 
tools is a prerequisite for the (heterologous) expression of BGCs or specific 589 
transcriptions factors (e.g. [37,144]). Co-cultivation experiments fall into the latter 590 
category and can be done without extensive knowledge of the strains used [2,6]. 591 
Further general approaches for “genome mining” rely on epigenetic factors involved 592 
in chromatin remodeling or global gene expression, either by using mutants or by 593 
adding exogenously chemical elicitors like valproic acid, 5-azacytidine or 594 
suberoylanilide hydroxamic acid [41–43,45–47,145,146]; on the exogenous addition 595 
of chemicals like GlcNAc, cAMP, FA synthesis inhibitors, antibiotics or quorum 596 
sensing molecules [29,81,139,140,147,148], rare earth elements like scandium [149]; 597 
or on the variations in the abiotic growth conditions (“OSMAC” approach [48]).  598 
Table I. Ways to activate the silent secondary metabolism of microorganisms.  599 
Approach Comments Potential for screenings Selected ref. 
Targeted-
expression of a 
given BGC 
Requires prior knowledge of the 
BGC and is often pathway 
specific (e.g. promoter swapping 
or heterologous cluster 
expression) 







Chemicals might be expensive 
or their bioavailability (e.g. 
diffusion in medium) might be 
low; screenings often based on 
phenotypic readouts (e.g. 




growth or medium 
conditions (e.g. 
OSMAC approach) 
Parallel experiments under 
different abiotic condition might 
be time-consuming 
Medium  [48]  
Use of mutants 
(e.g. 
developmental or 
Broad effects on secondary 
metabolism; might be used in 
combination with other 
Medium (strain specific) 










Often based on educated 
guesses or serendipitous 
discoveries of specific 
interactions; mixed culture 
experiments with three or more 
stains/species very rare 
Currently very limited. 
Might be greatly 
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